DNA double-helix binds regulatory peptides similarly to transcription factors

Khavinson V, Shataeva L, Chernova A. Neuroendocrinol Lett. 2005.

Organ: pineal-circadian · Type: review · Peptides: Epitalon

A complementarity model of Epitalon (AEDG) in the DNA major groove, proposing an ATTTC motif in the telomerase promoter — sequence analysis, not a wet-lab binding assay.

Editorial summary of a 2005 original article in Neuroendocrinology Letters. The work is geometric modeling and promoter-sequence analysis, not a cell-culture binding study and not a clinical trial. Public pages cite PubMed only. Read the paper: PMID 15990728.

Methods

The authors combined published DNA and peptide geometry with a complementary-binding model. They note that a peptide β-strand (about 3.47 Å per residue) and B-DNA (about 3.4 Å rise per base pair) can occupy the same length scale, and they place a stretched tetrapeptide in the major groove rather than the minor groove. Side-chain functional groups of Ala-Glu-Asp-Gly (Epitalon / Epithalon) were matched, by permutation of exposed donor, acceptor, and hydrophobic sites, to a short base-pair pattern. They then looked up that pattern in published promoter sequences for telomerase reverse transcriptase and for the large subunit of RNA polymerase II, and they compared Shannon information content of short peptide versus oligonucleotide blocks. No electrophoretic mobility-shift, footprinting, or co-crystal experiment is reported in this paper.

Findings

The model assigns ATTTC as a complementary site for AEDG; the authors also allow a weaker ATTTG match. The abstract names ATTTTC. They report that an ATTTC/G block appears repeatedly in the published promoter of the telomerase protein component (nine times in a 3729 bp segment from the transcription start, citing Wick, Zubov, and Hagen 1999) and three times in a promoter of the RNA polymerase II large subunit. They interpret complementary contact at those blocks as a possible way a short peptide could act like a transcription-factor agonist and, in their hypothesis, contribute to telomerase-promoter activity in somatic cells.

That reading is a structural hypothesis. This article does not demonstrate physical binding, does not measure telomerase, and does not test lifespan. Independent biochemical confirmation and human evidence are separate questions; they are not answered here. Follow the PMID.